Serial patent litigation: an emerging strategy to delay entry of generic competition
{{output}}
The Hatch-Waxman Act of 1984 was designed to accelerate generic drug entry by establishing a framework for resolving patent disputes between brand-name and generic manufacturers. While the Act has facilitated competition and expanded the availability of afford... ...
